1.Lemierre Syndrome
The Medical Journal of Malaysia 2012;67(3):340-341
Lemierre syndrome is an uncommon disease which
commonly arise from acute bacterial oropharyngeal
infection. This disease was first described in 1900 by
Courmont and Cade Lemierre. It is commonly caused by
Fusobacterium necrophorum1. Lemierre syndrome has been
reported to be serious and potentially fatal in the
preantibiotic era1. It is characterized by an oropharyngeal
infection leading to secondary septic thrombophlebitis of the internal jugular vein with embolization to the lungs and other organs. The incidence has become relatively rare at present and is usually only diagnosed when unsuspected
culture results are available1. We report a case of Lemierre syndrome which was recently diagnosed in our centre.
2.Two Cases of Nerve Sheath Myxomas.
Sang Hee YOO ; Young Gull KIM ; Ai Young LEE ; Jong Eun JOO ; Tuk Woo LIM ; Ji Young PARK ; Nack In KIM
Annals of Dermatology 2000;12(3):215-217
Nerve sheath myxoma(NSM) is a rare cutaneous neoplasm of uncertain histogenesis. NSM can be divided into two groups; NSM1 (a myxoid NSM) and NSM2 (a cellular neurothekeoma). NSMs are characterized histologically by well-defined, lobular or plexiform dermal proliferation of stellate, spindle-shaped cells embedded in abundant myxoid stroma. A variable amount of nerve fascicles are entrapped within and around the tumor. Two variants of NSM share the same features to a certain degree but differ in cellularity and mucin deposition. We report two cases of NSMs with different clinical and histopathologic features.
Mucins
;
Neurothekeoma*
3.Anesthesia for an Insulinoma Case .
Hyun Sook LEE ; Chung Ho SUH ; Dong Ai AN ; Sang Ho LIM ; Jung Soon SHIN
Korean Journal of Anesthesiology 1979;12(3):280-284
Hyperinsulinism caused by a functioning islet cell tumor of the pancreas is an uncommon but well established metabolic entity which can usually be diagnosed accurately. We treated a patient with functioning insulinoma recently. The outline of the particular management given for the course of the anesthesia of the patient was as follows: 1) Control of blood glucose a) pre- and intraoperative hypoglycemia; Glucose was administered through intravenous drip or orally. b) postoperative transient hyperglycemia; Insulin was administered if necessary and a small amount of glucose uptake, occurred. 2) Anesthetics, and supplemental drugs Drugs with no or little effect in increasing blood glucose were used. 3) Beta-adrenergic blockers These drugs were not used in the hypoglycemic state because of potentiating insulin activity.
Adenoma, Islet Cell
;
Adrenergic beta-Antagonists
;
Anesthesia*
;
Anesthetics
;
Blood Glucose
;
Glucose
;
Humans
;
Hyperglycemia
;
Hyperinsulinism
;
Hypoglycemia
;
Infusions, Intravenous
;
Insulin
;
Insulinoma*
;
Pancreas
4.Blockade of Vascular Endothelial Growth Factor (VEGF) Aggravates the Severity of Acute Graft-versus-host Disease (GVHD) after Experimental Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT).
Ai Ran KIM ; Ji Young LIM ; Dae Chul JEONG ; Gyeongsin PARK ; Byung Churl LEE ; Chang Ki MIN
Immune Network 2011;11(6):368-375
BACKGROUND: Recent clinical observation reported that there was a significant correlation between change in circulating vascular endothelial growth factor (VEGF) levels and the occurrence of severe acute graft-versus-host disease (GVHD) following allogeneic hematopoietic stem cell transplantation (allo-HSCT), but the action mechanisms of VEGF in GVHD have not been demonstrated. METHODS: This study investigated whether or not blockade of VEGF has an effect on acute GVHD in a lethally irradiated murine allo-HSCT model of B6 (H-2b)-->B6D2F1 (H-2b/d). Syngeneic or allogeneic recipient mice were injected subcutaneously with anti-VEGF peptides, dRK6 (50 microg/dose) or control diluent every other day for 2 weeks (total 7 doses). RESULTS: Administration of the dRK6 peptide after allo-HSCT significantly reduced survival with greaterclinical GVHD scores and body weight loss. Allogeneic recipients injected with the dRK6 peptide exhibited significantly increased circulating levels of VEGF and expansion of donor CD3+ T cells on day +7 compared to control treated animals. The donor CD4+ and CD8+ T-cell subsets have differential expansion caused by the dRK6 injection. The circulating VEGF levels were reduced on day +14 regardless of blockade of VEGF. CONCLUSION: Together these findings demonstrate that the allo-reactive responses after allo-HSCT are exaggerated by the blockade of VEGF. VEGF seems to be consumed during the progression of acute GVHD in this murine allo-HSCT model.
Animals
;
Body Weight
;
Graft vs Host Disease
;
Hematopoietic Stem Cell Transplantation
;
Hematopoietic Stem Cells
;
Humans
;
Mice
;
Oligopeptides
;
Peptides
;
T-Lymphocyte Subsets
;
T-Lymphocytes
;
Tissue Donors
;
Vascular Endothelial Growth Factor A
6.Vitiligo Lesions Improved after Oral Cyclosporine in a Patient with Vitiligo and Atopic Dermatitis.
Yunseok CHOI ; Won Suk LIM ; Sang Yun JIN ; Joon Ho LEE ; Seung Ho LEE ; Ai Young LEE
Korean Journal of Dermatology 2012;50(2):159-162
Vitiligo is an acquired cutaneous disorder of pigmentation with no definite etiology. Although there are a number of treatment modalities including phototherapy, topical corticosteroids and topical immunomodulators, few studies on the effect of systemic cyclosporine for the treatment of vitiligo have been conducted. We have experienced the improvement of vitiligo lesions after 8 months of systemic administration of cyclosporine (2.5~3.3 mg/kg/day) in a patient with vitiligo and atopic dermatitis. We believe this case report warrants further investigations of cyclosporine for the treatment of vitiligo in terms of mechanisms and clinical outcomes as well.
Adrenal Cortex Hormones
;
Cyclosporine
;
Dermatitis, Atopic
;
Humans
;
Immunologic Factors
;
Phototherapy
;
Pigmentation
;
Vitiligo
7.Nonpigmenting Fixed Drug Eruption due to Codeine.
Yunseok CHOI ; Won Suk LIM ; Sang Yun JIN ; Joon Ho LEE ; Seung Ho LEE ; Ai Young LEE
Korean Journal of Dermatology 2011;49(9):822-825
Fixed drug eruption is a distinctive and clinically recognizable entity that is characterized by well-demarcated erythematous plaques recurring in exactly the same sites as on previous occasions. Unlike the pigmenting form of fixed drug eruption, nonpigmenting fixed drug eruption leaves no pigmentation when it resolves. We now report the case of a 44-year-old man who presented with diffuse ill-defined erythematous patches on both hands, feet and lower legs with a burning sensation, which is considered an atypical manifestation for fixed drug eruption. The patient had a history of similar skin lesions developing after medications on the corresponding regions. The patch test with suspected drugs showed negative reactions on both lesions and unaffected sites. The lesions were reproduced on the oral provocation test with codeine and resolved without pigmentation. The patient was diagnosed with nonpigmenting fixed drug eruption due to codeine.
Adult
;
Burns
;
Codeine
;
Drug Eruptions
;
Foot
;
Hand
;
Humans
;
Leg
;
Patch Tests
;
Pigmentation
;
Sensation
;
Skin
8.Atypical Fibroxanthoma Masquerading as Xanthogranuloma.
Yunseok CHOI ; Won Suk LIM ; Sang Yun JIN ; Joon Ho LEE ; Seung Ho LEE ; Jong Sun CHOI ; Eo Jin KIM ; Ai Young LEE
Korean Journal of Dermatology 2011;49(4):360-364
Atypical fibroxanthoma is an uncommon spindle cell tumor that has a clinically benign course despite the presence of bizarre xanthoma cells. A 90-year-old female presented with a 2-month history of an ulcerative plaque on the right cheek. The initial punch biopsy revealed a benign histological appearance with prominent xanthomatous cells, but the specimen excised afterwards showed malignant features with a spindle and epithelioid cell proliferation with pleomorphism and atypia. The tumor cells stained positively for vimentin and CD68, they were partially positive for CD99 and CD10 and they were negative for CD34, S100, p63, desmin and actin. We report here on a case of atypical fibroxanthoma masquerading as xanthogranuloma.
Actins
;
Aged, 80 and over
;
Biopsy
;
Cheek
;
Desmin
;
Diagnosis, Differential
;
Epithelioid Cells
;
Female
;
Humans
;
Ulcer
;
Vimentin
;
Xanthomatosis
9.Pacinian Neuroma on the Tips of Fingers.
Yunseok CHOI ; Won Suk LIM ; Sang Yun JIN ; Joon Ho LEE ; Ai Young LEE ; Seung Ho LEE
Korean Journal of Dermatology 2011;49(9):847-849
Pacinian neuroma, also known as hyperplasia and/or hypertrophy of pacinian corpuscles is a rare skin condition usually occurring in the hand. Although it is known to cause pain and tenderness on the affected skin, asymptomatic cases have also been reported. We report a 46-year-old male monk who presented with asymptomatic skin lesions of paler color than the adjacent normal skin on the tips of the fingers of both hands. The 3 mm punch biopsy conducted on the lesion showed an increased number of onion bulb-like structures with a nerve fiber in each center. The patient was diagnosed with pacinian neuroma and has been under regular follow up without treatment.
Biopsy
;
Fingers
;
Follow-Up Studies
;
Hand
;
Humans
;
Hyperplasia
;
Hypertrophy
;
Male
;
Middle Aged
;
Nerve Fibers
;
Neuroma
;
Onions
;
Pacinian Corpuscles
;
Skin
10.Longitudinal Growth of Hospitalized Very Low Birth Weight Infants.
Seo Young LEE ; Jae Woo LIM ; Nu Lee JUN ; Ai Rhan KIM ; Ki Soo KIM ; Soo Young PI
Journal of the Korean Society of Neonatology 2003;10(2):125-132
PURPOSE: This study was performed to investigate the postnatal growth for very low birth weight infants (VLBWI) and to evaluate the factors associated with growth during initial hospitalization. METHODS: The subjects for the study included 155 infants, birth weight less than 1, 625 g, who were admitted to neonatal intensive care unit of Asan Medical Center from January of 1999 to May of 2002. Infants with twin or triplet, necrotizing enterocolitis, small for gestational age and congenital abnormality were excluded. Nutrient intakes and body weights were recorded daily during the first 8 days, 11th and 14th day and then weekly after the 14th day. Length and head circumference were measured weekly. All of the data was collected up to postnatal 105 days or hospital discharge. Enteral plus parenteral fluid, calory, and protein intake were evaluated daily. RESULTS: Growth curves were made according to four birth weight groups: group of 750 g (625-874 g), 1, 000 g (875-1, 124 g), 1, 250 g (1, 125-1, 374 g), 1, 500 g (1, 375-1, 624 g), respectively. Mean fluid intake was 143.7 +/- 24.9 mL/kg/d, caloric intake was 78.1 +/- 10.5 kcal/kg/d and protein intake was 2.4 +/- 0.3 g/kg/d. The mean period to regain birth weight was 19.9 +/- 7.8 days and 25.4 +/-11.0, 22.2 +/- 7.5, 18.8+/- 7.3, 17.3 +/- 6.2 days were required, to regain birth weight for previously mentioned birth weight groups, respectively. Birth weight, gestational age, duration of total parenteral nutrition, age at starting of enteral feeding were negatively associated with the mean duration to regain birth weight. Duration of respiratory support and supplemental oxygen were negative predictors, unlike protein intake which revealed to be a positive predictor. CONCLUSION: Postnatal growth curves of VLBW infants were based on body weight, length, head circumference. Birth weight, gestational age, duration of total parenteral fluid, age at starting of enteral feeding were negatively associated with the mean duration to regain birth weight. There was a positive correlation with protein intake. More rapid regain to birth weight was associated with a shorter duration of respiratory support and supplemental oxygen.
Birth Weight
;
Body Weight
;
Chungcheongnam-do
;
Congenital Abnormalities
;
Energy Intake
;
Enteral Nutrition
;
Enterocolitis, Necrotizing
;
Gestational Age
;
Head
;
Hospitalization
;
Humans
;
Infant*
;
Infant, Newborn
;
Infant, Very Low Birth Weight*
;
Intensive Care, Neonatal
;
Oxygen
;
Parenteral Nutrition, Total
;
Triplets
;
Twins